Shanghai Pioneer Holding Ltd

Equities

1345

KYG2162L1068

Pharmaceuticals

Delayed Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
1.88 HKD +10.59% Intraday chart for Shanghai Pioneer Holding Ltd +32.39% +2.73%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shanghai Pioneer Holding's 2023 Profit Falls as Revenue Stays Flat MT
Shanghai Pioneer Holding Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Pioneer's Unit Acquires Q3 Medical Devices' Intellectual Property Rights MT
Shanghai Pioneer Holding Ltd Announces Board Changes CI
Shanghai Pioneer Holding Ltd Announces Change of Address of Registered Office CI
Shanghai Pioneer Holding Ltd(SEHK:1345) dropped from S&P Global BMI Index CI
Shanghai Pioneer Holding Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Pioneer Holding Ltd Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on October 20, 2023 CI
Shanghai Pioneer Holding Ltd Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 15 June 2023 CI
Shanghai Pioneer Holding Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Pioneer Sees 40% Rise in FY22 Profit MT
Shanghai Pioneer Holding Ltd Provides Earnings Guidance for the Year Ended 31 December 2022 CI
Shanghai Pioneer Holding Unit to Inject 50 Million Yuan in Environmental Protection Company MT
Shanghai Pioneer Holding Enters $69 Million Production Line Contracts MT
China Pioneer Pharma Changes Name to Shanghai Pioneer Holding MT
China Pioneer Pharma Holdings Limited has Changed its Name to Shanghai Pioneer Holding Ltd CI
China Pioneer Pharma's H1 Profit Surges 78% MT
Shanghai Pioneer Holding Ltd(SEHK:1345) added to S&P Global BMI Index CI
China Pioneer Pharma Holdings Limited Announces Management Changes CI
China Pioneer Pharma Holdings Limited Announces Resignation of Luo Chunyi as Chief Executive Officer CI
China Pioneer Pharma Proposes Name Change; Shares Rally 14% MT
China Pioneer Pharma Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 20 October 2022 CI
China Pioneer Pharma Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
China Pioneer Pharma Signs $4.5 Million Structured Deposit Agreement MT
China Pioneer Pharma Signs $149.2 Million Production Line Deal with Dalian Xinxindingnuo Trading MT
Chart Shanghai Pioneer Holding Ltd
More charts
Shanghai Pioneer Holding Ltd, formerly China Pioneer Pharma Holdings Ltd, is a China-based investment holding company mainly engaged in the marketing, promotion and sales of pharmaceutical products, medical devices and personal protective equipment. The Company operates mainly through three segments. The Products Sold via the Provision of Channel Management Services segment is principally engaged in the sales of the Company's ophthalmic pharmaceutical products to customers through pipeline management arrangements. The Products Sold via the Provision of Comprehensive Marketing, Promotion and Channel Management Services segment is principally engaged in the sale of all of the Company's pharmaceutical products and medical devices to customers through comprehensive marketing, promotion and channel management arrangements. The Sales of Personal Protective Materials segment is mainly engaged in the sales of personal protective materials include masks, protective gloves and protective suits.
More about the company
  1. Stock
  2. Equities
  3. Stock Shanghai Pioneer Holding Ltd - Hong Kong S.E.
  4. News Shanghai Pioneer Holding Ltd
  5. China Pioneer Pharma Arm to Invest Over $4 Million in Chinese Conglomerate